Cerebras Systems has again made a confidential filing for a U.S. public offering, according to people with knowledge of its plans. The designer of AI chips and systems has been meeting with ...

By Ateev Bhandari Feb 19 (Reuters) - Wall Street broker Clear Street on Thursday pulled its U.S. listing plan a week after ...

The Northridge, California-based firm plans to market 28 million shares for $25 to $28 each, according to its filing Tuesday with the US Securities and Exchange Commission. The IPO is expected to ...

The Somerville-based company, which uses its proprietary AI system in drug engineering and development, is seeking to go public amid a jump in biotech and pharma IPO volume.

A potential record-setting SpaceX initial public offering has sent Wall Street into overdrive. Main Street wants a cut of the action. Bankers and institutional investors who talk to SpaceX executives ...

EIR Biopharma is hoping to bring in $17.1 million from an IPO on the New York Stock Exchange that could fund development of its preclinical eye disease drug. | EIR Biopharma is hoping to bring in $17.

The asset manager is expected to submit its draft red herring prospectus in the first half of March.

The confidential filing with the SEC for a US initial public offering came less than a week after Grayscale Investments announced a similar move. Kraken, the US cryptocurrency exchange headquartered ...

NEW YORK, Dec 19 (Reuters) - AI chip ‌maker Cerebras Systems is preparing to ‌file for a U.S. initial public offering as soon as next week, targeting a second-quarter 2026 listing, people familiar ...